A HEAD‐TO‐HEAD PHASE 3 STUDY COMPARING BGB‐3111 AND IBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA. (June 2017) - Buske, C.; LeBlond, V.; Novotny, W.; Owen, R.; Tedeschi, A.; Atwal, S.; Cohen, A.; Huang, J.; Tam, C.S.